StonvexLoading…
StonvexStonvexStonvexCore line items from LHX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-03 | Annual 2026 2026-01-02 | Q4 2025 2025-10-03 | Q2 2025 2025-06-27 |
|---|---|---|---|---|
Revenue | $5.74B | $21.86B | $16.22B | $10.56B |
Operating Income | $652.00M | $2.11B | $1.72B | $1.10B |
Net Income | $512.00M | $1.61B | $1.31B | $844.00M |
EPS (Diluted) | $2.72 | $8.53 | $6.92 | $4.48 |
Total Assets | $41.38B | $41.20B | $41.01B | $41.24B |
Total Liabilities | $21.70B | $21.56B | $21.48B | $21.96B |
Cash & Equivalents | $590.00M | $1.07B | $339.00M | $482.00M |
Free Cash Flow OCF − CapEx | $-194.00M | $2.68B | $878.00M | $451.00M |
Shares Outstanding | 186.60M | 186.84M | 187.17M | 186.91M |